Stable Chronic AnginaNCT03911895
Impact of Stent Length on Short Term Outcomes in Patients With Stable Coronary Disease Undergoing PCI
An observational study of Stable Chronic Angina, run by Assiut University at 1 site in Egypt.
Trial summary
Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI Read more about this study
- Who is it for?
- Ages 25 to 80 years
- Conditions the study is for
- Stable Chronic Angina
- What is being tested?
- Stent more than 26 mn length and Stent equal to or less than26 mn length
- Type of treatment
- Medical device
- How many people
- 1 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jul 2019to 30 Sep 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 80 years
- All sexes
- Adult, Older adult
Study population: Patients with stable coronary artery disease undergoing PCI
Who may be able to join
- patient was CAD referred for elective PC as single vessel
Who cannot join
- patients admitted ACS patients with primary PCI PTCA without stenting No complete revascularization PCI-related coronary complication (diessaction,no really)
Trial locations and contacts
1 site in 1 country.
Egypt1 site, 1 recruiting
- Recruiting
Mohamed abdelbast
Asyut, 23123
Mohamed Donkol, +201002078279, Mohameddonkol141291@gmail.com
About this study
Official title: Impact of Stent Length on Short Term Outcomes in Patients With Stable Coronary Artery Disease Undergoing PCI
Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI
Read the detailed description
Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI. The investigators will follow up patient clinically and use lab investigation.
- Conditions
- Stable Chronic Angina
- Being tested
- Stent more than 26 mn length, Stent equal to or less than26 mn length
- Medical subject headings
- Angina, Stable
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Stent more than 26 mn lengthDevice
stent length in patients undergoing PCI (Drug Eluting Stent)
Stent equal to or less than26 mn lengthDevice
stent length in patients undergoing PCI (Drug Eluting Stent)
| Study group | Role | What they receive |
|---|---|---|
| patients with coronary artery diseas undergoing PCI | Effect of stent length on patients with coronary artery undergoing PCI Receives: Device: Stent more than 26 mn length; Device: Stent equal to or less than26 mn length |
What is being measured
The primary outcome is the main question the study is designed to answer.
Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI
to study effect of stent length in patients undergoing PCI
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Apr 2019
- Study start1 Jul 2019 (estimated)
- Primary completion30 Jun 2020 (estimated)
- Study completion30 Sep 2020 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Stable Chronic AnginaStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Abd elbaset Hassan, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03911895
- Sponsor's protocol ID
- Stent length impact on PCI
- Status last verified
- Mar 2019
- First submitted
- 26 Mar 2019
- Last updated
- 11 Apr 2019
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 11 Apr 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Stent Length on Short Term Outcomes in Patients With Stable Coronary Artery Disease Undergoing PCI
- ClinicalTrials.gov ID
- NCT03911895
- Acronym / sponsor ID
- Stent length impact on PCI
- Conditions
- Stable Chronic Angina
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 1 Jul 2019 (estimated)
- Primary completion
- 30 Jun 2020 (estimated)
- Study completion
- 30 Sep 2020 (estimated)
- First posted
- 11 Apr 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI
Detailed description
Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI. The investigators will follow up patient clinically and use lab investigation.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| patients with coronary artery diseas undergoing PCI | – | Device: Stent more than 26 mn length, Device: Stent equal to or less than26 mn lengthEffect of stent length on patients with coronary artery undergoing PCI |
Who may qualify
- Ages
- 25 to 80 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Patients with stable coronary artery disease undergoing PCI
Key inclusion criteria (1 listed)
- patient was CAD referred for elective PC as single vessel
Key exclusion criteria (1 listed)
- patients admitted ACS patients with primary PCI PTCA without stenting No complete revascularization PCI-related coronary complication (diessaction,no really)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Stent more than 26 mn lengthstent length in patients undergoing PCI (Drug Eluting Stent) | Device | patients with coronary artery diseas undergoing PCI |
| Stent equal to or less than26 mn lengthstent length in patients undergoing PCI (Drug Eluting Stent) | Device | patients with coronary artery diseas undergoing PCI |
Primary outcome
Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI
Time frame: 3 months
to study effect of stent length in patients undergoing PCI
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Apr 2019.
Related trials for Stable Chronic Angina
Recruiting
Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With Stable Angina or ACS - A Traditional Feasibility Study
Coronary Arterial Disease (CAD), Plaque
Recruiting
Multivessel Balloon Occlusion to Investigate Obstructive Coronary Artery Disease and aNgina
Stable Angina, Multivessel Coronary Artery Disease
Recruiting
Study of Lesion-Specific Invasive Haemodynamic Angina Thresholds
Angina (Stable), Coronary Artery Disease(CAD)
Active, not recruitingObservational study
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
Angina Pectoris, Angina Pectoris, Stable
RecruitingObservational study
Identification of Lesion Characteristics in Coronary Plaques Using Multimodality Intravascular Imaging and Novel Photon-counting CT in Stable Angina
Coronary Artery Disease (CAD), Stable Angina Pectoris
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Stable Chronic Angina, run by Assiut University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 11 Apr 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Mohamed Donkol (+201002078279, Mohameddonkol141291@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Apr 2019.